Back to Search
Start Over
Fractionating heparins and their clinical trial data-something for everyone
- Source :
- JAMA, The Journal of the American Medical Association. July 7, 2004, Vol. 292 Issue 1, p101, 3 p.
- Publication Year :
- 2004
-
Abstract
- Heparin is known to reduce ischemic occurrences beyond that of aspirin in acute coronary setting and unfractionated heparin is known to have several limitations and inability to inhibit clot-bound thrombin. Trials show that enoxaparin is a good alternative to unfractionated heparin in regular acute coronary syndrome (ACS) treatment.
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 292
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- JAMA, The Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.122664881